THU-144-Ledipasvir/sofosbuvir for 8, 12, or 24 weeks is safe and effective in patients undergoing dialysisWan‐Long Chuang, Alessandra Mangia, Peter Buggisch et al.|Journal of Hepatology|2019Cited by 7